Floatz logo

NEPENTHE

Traumatic Brain Injury

Henry M. Jackson Foundation for the Advancement of Military MedicineSmall moleculePhase 4 / ApprovedActive
BB
71/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
95/ 100

Competitive context

82 Active assets in the Traumatic Brain Injury cohort.

Asset / SponsorPhaseRating
MELATONIN
Children's National Research Institute
Phase 4BBB
Valproic Acid
Northwestern University
Phase 4BBB
Apsolol
Tanta University
Phase 4BBB
Dexmedetomidine
Universitas Jenderal Soedirman
Phase 4BB
Amantadine
SHINKEI Therapeutics, Inc
Phase 4BB

View all 50 →

Same molecule, other indications

NEPENTHE is also rated in:

cancer of unknown primary siteDormant
BBB
Indicative · Phase 4
75 / 100
View asset →
chronic pain syndromeActive
BBB
Indicative · Phase 4
74 / 100
View asset →
post-operative pain, non-human animalActive
BBB
Indicative · Phase 4
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →